Modern strategies in therapy of organophosphate poisoning

Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics

Franz Worek, Christine Diepold, Peter Eyer · Archives of Toxicology · 1999 · 166 citations

Life Sciences, Biochemistry, Pharmacology +10

Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning

Franz Worek, M. Bäcker, Horst Thiermann et al. · Human & Experimental Toxicology · 1997 · 159 citations

Pharmacy, Pharmacology, Toxicology +17

Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients

Horst Thiermann, Ulrike Mast, R. Klimmek et al. · Human & Experimental Toxicology · 1997 · 130 citations

Medicine, Pharmacokinetics, Pharmacology +14

Minimum concentrations of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block

Anders Sundwall · Biochemical Pharmacology · 1961 · 117 citations

Medicine, Neuroscience, Pharmacology +16

Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphate

J. Willems, Herbert C. De Bisschop, Alain Verstraete et al. · Archives of Toxicology · 1993 · 92 citations

Pharmacy, Pharmacology, Toxicology +11